197 related articles for article (PubMed ID: 18658008)
1. Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy.
Nart A; Uslu A; Aykas A; Yuzbasioglu F; Dogan M; Demirtas O; Simsek C
Asian J Surg; 2008 Jul; 31(3):115-8. PubMed ID: 18658008
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy.
Takamura Y; Nakano K; Uruno T; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Endocr J; 2003 Oct; 50(5):595-601. PubMed ID: 14614216
[TBL] [Abstract][Full Text] [Related]
3. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
4. Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.
De Bellis A; Conzo G; Cennamo G; Pane E; Bellastella G; Colella C; Iacovo AD; Paglionico VA; Sinisi AA; Wall JR; Bizzarro A; Bellastella A
Endocrine; 2012 Apr; 41(2):320-6. PubMed ID: 22169963
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up.
Barczyński M; Konturek A; Hubalewska-Dydejczyk A; Gołkowski F; Nowak W
Br J Surg; 2012 Apr; 99(4):515-22. PubMed ID: 22287122
[TBL] [Abstract][Full Text] [Related]
6. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
7. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
[TBL] [Abstract][Full Text] [Related]
8. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
9. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
[TBL] [Abstract][Full Text] [Related]
10. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
11. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
[TBL] [Abstract][Full Text] [Related]
13. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
14. TSH receptor autoantibody levels post-total thyroidectomy in Graves' ophthalmopathy: a meta-analysis.
Anees A; Ayeni FE; Eslick GD; Edirimanne S
Langenbecks Arch Surg; 2023 Oct; 408(1):415. PubMed ID: 37870639
[TBL] [Abstract][Full Text] [Related]
15. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease.
Yoshioka W; Miyauchi A; Ito M; Kudo T; Tamai H; Nishihara E; Kihara M; Miya A; Amino N
Endocr J; 2016; 63(2):179-85. PubMed ID: 26632172
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
Palit TK; Miller CC; Miltenburg DM
J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
[TBL] [Abstract][Full Text] [Related]
19. Thyroidectomy remains an effective treatment option for Graves' disease.
Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
[TBL] [Abstract][Full Text] [Related]
20. Graves' ophthalmopathy after total thyroidectomy for papillary carcinoma.
Giovansili L; Cayrolle G; Belange G; Clavel G; Herdan ML
Ann Endocrinol (Paris); 2011 Feb; 72(1):42-4. PubMed ID: 21195999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
